Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 2,437 | 780 | 630 | 1,157 | 622 |
| Operating Income | -2,437 | -780 | -630 | -1,157 | -622 |
| Interest Expense | 438 | 778 | 829 | 307 | 1,353 |
| Other Income | 0 | 0 | 0 | -1 | 0 |
| Pre-tax Income | -2,875 | -1,558 | -1,459 | -1,465 | -1,975 |
| Net Income Continuous | -2,875 | -1,558 | -1,459 | -1,465 | -1,975 |
| Net Income | $-2,875 | $-1,558 | $-1,459 | $-1,465 | $-1,975 |
| EPS Basic Total Ops | -0.18 | -0.26 | -0.25 | -0.43 | -0.38 |
| EPS Basic Continuous Ops | -0.18 | -0.26 | -0.24 | -0.42 | -0.37 |
| EPS Diluted Total Ops | -0.18 | -0.26 | -0.25 | -0.43 | -0.38 |
| EPS Diluted Continuous Ops | -0.18 | -0.26 | -0.24 | -0.42 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.18 | -0.26 | N/A | N/A | N/A |
| EBITDA(a) | $-2,099 | $308 | $-630 | $-944 | $362 |